Randomised crossover trial of salbutamol aerosol delivered by metered dose inhaler, jet nebuliser, and ultrasonic nebuliser in chronic lung disease
Department of Paediatrics, The Chinese University of
Hong Kong, The Prince of Wales Hospital, Shatin, Hong Kong, People's
Republic of China
Correspondence to: Dr T F Fok.
Accepted 4 February 1998
AIMS
To compare the efficacy of salbutamol
delivered by metered dose inhaler (MDI), jet nebuliser, and ultrasonic
nebuliser in ventilated infants with chronic lung disease.
METHODS
Twenty preterm ventilated infants with
chronic lung disease were enrolled in two studies. In study 1 (n=10),
each infant was given 200 µg of salbutamol at 4 hour intervals and in
random sequence from a metered dose inhaler-spacer device, a jet
nebuliser, and an ultrasonic nebuliser with a small medication cup. The
infants were monitored for heart rate, transcutaneous pO2,
pCO2, and oxygen saturation, respiratory system resistance
and compliance before and after each treatment. Infants in study 2 (n=10) were similarly studied except for the use of a different jet nebuliser.
RESULTS
The mean (SEM) maximum percentage
decreases in respiratory system resistance, observed at 30 minutes
after aerosol delivery were study 1: MDI: 44.3 (4.3)% ; jet: 32.3 (3.4)% ; ultrasonic: 56.1 (3.2)% ; study 2: MDI: 28.6 (1.0)% ; jet:
16.9 (1.4)% ; ultrasonic: 42.1 (1.6)%. During the first hour after
treatment, a significantly faster heart rate and higher transcutaneous
pO2 were associated with the use of the ultrasonic
nebuliser or MDI than with the jet nebulisers in both studies. The use
of the ultrasonic nebuliser but not the other devices also resulted in
a lower transcutaneous pCO2 and improved respiratory system
compliance in study 2.
CONCLUSIONS
These findings suggest that
among the devices tested, the delivery of salbutamol aerosol to the
lower respiratory tract was greatest using the ultrasonic nebuliser,
and least with the jet nebulisers.
© 1998 by Archives of Disease in Childhood
This article has been cited by other articles:
-
(2003). Statement on the Care of the Child with Chronic Lung Disease of Infancy and Childhood. Am. J. Respir. Crit. Care Med.
168: 356-396
[Full Text] -
Palmer, D., Schurch, S., Belik, J.
(2000). Effect of budesonide and salbutamol on surfactant properties. J. Appl. Physiol.
89: 884-890
[Abstract] [Full Text]
Register for free content
The full back archive is now available for all BMJ Journals. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006 right back to volume 1 issue 1. Register here to access the free archive of all BMJ Journals.
Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.



